NCT03427086View on ClinicalTrials.gov

Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 29, 2018

Primary Completion Date

May 10, 2021

Study Completion Date

May 10, 2021

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

Biotin

High dose biotin

DRUG

Placebo Oral Tablet

Placebo tablet similar in shape and size to the biotin tablet

Trial Locations (1)

1107 2020

American univeristy of Beirut medical center, Beirut

All Listed Sponsors
lead

American University of Beirut Medical Center

OTHER

NCT03427086 - Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter